6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: NeuroSense Therapeutics Ltd.
Filed: October 30, 2024
Period of Report: October 30, 2024
Accession Number: 0001213900-24-092005

View Document ↗ View on SEC.gov ↗